Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,376 total articles
Alico, Inc., a diversified agribusiness and land management company, announced that its CEO, John Kiernan, will present and hold one-on-one meetings with investors at the LD Micro Invitational XVI conference in Los Angeles from May 17-19, 2026. The company recently completed a strategic transformation in 2025 and manages approximately 46,000 acres …
Axe Compute Inc. announced its CEO Chris Miglino will appear on Schwab Network and Cheddar to discuss the company's significant growth, highlighted by a $260 million, three-year enterprise contract for a 2,304-GPU NVIDIA B300 deployment—the largest in Axe Compute’s history. The interviews aim to increase visibility for its neocloud AI infrastructur…
NewGenIVF Group reported robust fiscal year 2025 results highlighted by a significant increase in total assets to $32.7 million and net profit attributable to shareholders of $9.9 million, largely from a bargain purchase gain linked to acquisitions. The company made strategic advances in diversifying its business through expansions in digital asset…
Reliance Global Group, through its biotech division LifeSci Global, completed a strategic investment in Innervate Radiopharmaceuticals, a late-stage developer of PET imaging and therapeutic radiopharmaceuticals focused initially on neuroblastoma with expansion potential in cardiovascular and neurodegenerative diseases. This investment aligns with R…
Candel Therapeutics announced a conference call scheduled for May 15, 2026, to discuss extended follow-up data from the phase 3 clinical trial of aglatimagene besadenovec in intermediate- to high-risk localized prostate cancer, presented at the American Urological Association annual meeting. The call will feature leading prostate cancer specialists…
Athene, a subsidiary of Apollo Global Management, has launched Athene Amplify 3.0, an upgraded registered index-linked annuity (RILA). The new product features expanded buffer options to cater to varied risk appetites, a simplified single-contract structure to streamline the client and financial professional experience, and innovative features like…
Diana Shipping Inc. initiated a fully financed tender offer to acquire all outstanding shares of Genco Shipping & Trading at $23.50 per share in cash, representing a 31% premium to Genco's undisturbed share price. This comes after Genco's Board has refused engagement for five months despite multiple offers. Diana aims to deliver immediate value to …
Vera Therapeutics, a US biotechnology company focused on transformative treatments for immunological diseases, announced its management team will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas, NV. The presentation will include updates on its lead drug candidates atacicept, VT-109, and MAU868, targeting autoimmun…
Tyson Foods, a leading protein company, announced the availability of its second quarter 2026 financial results on its investor relations website. The company will host a conference call and webcast to discuss the results. The earnings release will also be filed with the SEC. Tyson Foods is a well-established company with various iconic food brands…
InflaRx N.V. announced new preclinical data showing that izicopan, their investigational oral C5aR1 inhibitor, demonstrates minimal reactive metabolite formation in human liver microsomes, indicating a potentially safer bioactivation profile compared to the marketed drug avacopan. Izicopan has shown strong pharmacokinetic/pharmacodynamic and safety…
FG Nexus has formed a Special Committee of independent directors to evaluate strategic alternatives, including a potential business combination with FG Communities, a real estate investment company focused on manufactured affordable housing communities. The combination aims to build a leading platform integrating income-producing affordable housing…
Rekor Systems has secured a $16.8 million contract with the Oklahoma District Attorneys Council to continue providing technology for the state's Uninsured Vehicle Enforcement Diversion (UVED) Program. Utilizing advanced AI-powered vehicle recognition sensors, Rekor's technology helps identify uninsured drivers, reducing uninsured motorist rates and…
Hubbell Incorporated announced the acquisition of NSI Industries, a leading manufacturer of electrical fittings and components, for $3 billion in cash. The transaction is expected to strengthen Hubbell's Electrical Solutions segment by adding complementary products and brands, supporting long-term growth driven by electrification trends. The deal i…
Palvella Therapeutics has initiated patient dosing in the Phase 2 LOTU trial evaluating its Fast Track-designated QTORIN™ 3.9% rapamycin anhydrous gel for treating clinically significant angiokeratomas, a rare and debilitating vascular malformation with no approved therapies. The single-arm trial plans to enroll up to 15 patients at U.S. vascular a…
K Wave Media Ltd. (NASDAQ: KWM) announced a strategic transformation involving the sale of its legacy business Play Co., Ltd., eliminating approximately $48 million in debt, and a pivot towards developing and investing in AI infrastructure. The company secured expanded capital access of up to $485 million from Anson Funds to fund this AI infrastruc…
BridgeBio Pharma announced new data presentations from the Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy at the upcoming ESC Heart Failure 2026 conference. The data highlights acoramidis' positive impact on heart failure progression, biomarkers, and clinical outcomes, supporting its established role in reducing c…
MacroGenics, Inc., a clinical-stage biopharmaceutical company, announced an expanded royalty purchase agreement with Sagard Healthcare Partners involving its cancer drug ZYNYZ® (retifanlimab-dlwr). The deal provides MacroGenics a $60 million upfront payment and potential additional milestones, while Sagard receives capped royalty interests on globa…
L.B. Foster Company announced strong financial results for Q1 2026 with net sales rising 23.9% to $121.1 million, driven primarily by a 38.4% increase in Rail segment sales. The company reported net income of $1.5 million, a significant turnaround from a loss last year, and EBITDA growth of 183%, supported by increased volume and improved gross pro…
Micropolis AI Robotics, a UAE-based autonomous mobile robot developer listed on NYSE American, announces the launch of its next-generation M1.5 hybrid robot. This enhanced platform features improved off-road mobility, higher endurance, and operational resilience tailored for mission-critical applications in security, surveillance, and industrial en…
Healthcare Realty Trust Incorporated, a leading U.S. owner and operator of medical outpatient buildings, announced a private offering of $500 million in exchangeable senior notes due 2032. The proceeds will be used partly to enter capped call transactions, repurchase up to $75 million of common stock, and refinance existing debt due in 2026. The of…
Compass Diversified (NYSE: CODI) finalized the sale of its majority-owned subsidiary Sterno's food service business to Archer Foodservice Partners for approximately $280 million after adjustments. The proceeds will be used to repay senior secured debt, reducing the company's net leverage ratio to below 1.0x by June 30, 2026, avoiding fees related t…
SOLV Energy, a Nasdaq-listed infrastructure services provider for the power industry, will release its first quarter 2026 financial results on May 12, 2026, followed by a management conference call and webcast. The company specializes in engineering, procurement, construction, operations, maintenance, and repowering of power infrastructure.
NextCure, Inc. in partnership with Simcere Zaiming Pharmaceutical have initiated the dose optimization phase of their Phase 1 clinical trial for SIM0505, an antibody drug conjugate targeting cadherin-6 for treating platinum-resistant ovarian cancer. SIM0505 has received Fast Track designation from the FDA, and the companies are expanding their clin…
Pasithea Therapeutics, a US-based clinical-stage biotech company, announced the appointment of Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer. Dr. Krishnan brings extensive experience in clinical development, particularly with MEK inhibitors, having contributed to the FDA approval of cobimetinib. He will oversee clinical strategy for PAS-00…
Indivior Pharmaceuticals announced a $175 million accelerated share repurchase agreement with Barclays, utilizing part of its ongoing $400 million buyback program. The company aims to demonstrate confidence in its long-term strategy and financial strength without altering prior financial guidance. The ASR will initially repurchase 3.7 million share…
